COMPANY

AeroCytek, Inc

HQ: San Diego, CA source · aerocytek.com ↗ · West Coast

AeroCytek, Inc., the successor-in-interest to the R&D-focused Diagnologix, LLC in 2024, specializes in phospholipid microbubble-based cell processing to address manufacturing bottlenecks in clinical applications, offering enhanced capabilities and a broader market reach. From company website Source · Oct 13, 2026

Keywords: From press sources: cell therapy CAR-T

Profile checked Oct 10, 2026

2NIH grants

NIH awards 2

Annual award amounts. Total $500K.

Sep 17, 2025 NIH award 1R43CA298530-01 FY2025: $400,000 awarded for that fiscal year; activity R43 (SBIR); PI LIU, YU-TSUENG; recipient as written: AEROCYTEK, INC., SAN DIEGO, CA. Point-of-care autologous CAR-T cell manufacturing source ↗
May 12, 2025 NIH award 6R44CA265468-04 FY2023: $100,000 awarded for that fiscal year; activity R44 (SBIR); PI SHI, GUIXIN; recipient as written: AEROCYTEK, INC., SAN DIEGO, CA. Toward GMP production of antigen specific regulatory source ↗

Connect

Contact page